Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Treating HCV in HIV 2013: On the cusp of change
Valérie Martel-Laferrière
,
Douglas T. Dieterich
Hepatology Transplant Fellowship Program
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Liver Diseases
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treating HCV in HIV 2013: On the cusp of change'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatitis C Virus
100%
Cusp
100%
Co-infected Patients
75%
Direct-acting Antivirals
50%
Ribavirin
25%
New Drugs
25%
Hepatitis C
25%
Infected Patients
25%
Sustained Virological Response
25%
Pegylated Interferon
25%
Medicine and Dentistry
Hepatitis C Virus
100%
Human Immunodeficiency Virus
100%
Antiviral Drug
50%
Ribavirin
25%
Hepatitis C
25%
Peginterferon
25%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Hepatitis C Virus
100%
Antiviral Drug
50%
Hepatitis C
25%
Ribavirin
25%
Peginterferon
25%
Immunology and Microbiology
Hepatitis C Virus
100%
Human Immunodeficiency Virus
100%
Hepatitis C
25%
Pegylated Interferon
25%
Ribavirin
25%